Breaking News

Vyteris Restructures as Specialty CRO

Vyteris, Inc. is realigning the company in an effort to become a diversified specialty CRO.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Vyteris, Inc. is realigning the company in an effort to become a diversified specialty CRO. This decision follows on the company’s merger with CRO, MediSync BioServices, Inc. Vyteris will now focus all its efforts on consolidating specialty businesses in the CRO, site management organization (SMO) and related services industry. The company is discontinuing its drug delivery business and plans to sell its active transdermal drug-delivery assets. Vyteris aims to bring together established and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters